There is a focus on optimizing early phase clinical trials, particularly in areas such as oncology, to minimize risk and improve decision-making. The use of artificial intelligence and innovation in clinical trials is also being explored, with potential applications in fields like radiation therapy and precision medicine. Additionally, regulatory guidance is being issued, with the FDA providing new guidance on clinical trial dosage for certain oncology treatments.